GenSight Biologics Reports €3.4 Million Cash Position as of September 30, 2024, and Business Update GenSight Biologics (“GenSight” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharmaceutical company dedicated to developing innovative gene therapies for retinal neurodegenerative diseases…
Launch of Access to Health Initiative Announced at World Stroke Congress The World Stroke Organization (WSO) President, Dr. Sheila Martins, officially launched the Access to Health initiative at the annual World Stroke Congress in Abu Dhabi. This collaboration with Merz…
eyonis™ LCS Achieves Key Milestones in REALITY Study; Upcoming Webcast Scheduled Key Highlights: Operational and Financial Overview:Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced that its Board of Directors approved the consolidated IFRS financial statements for H1 2024 on October 23,…
Shields Health Solutions (Shields), a leading specialty pharmacy accelerator and a Walgreens-owned company, has expanded its partnership with Sutter Health, one of the largest nonprofit health systems in the U.S., to increase patient access to specialty medications for chronic, rare,…
YourHealth Launches YourHealth Life: A Revolutionary Subscription-Based Health Management Tool YourHealth, a leader in consumer-controlled health applications, is thrilled to announce the launch of YourHealth Life, an innovative suite of subscription-based features designed to significantly enhance the consumer health management…
Valor Compounding Pharmacy Invites New Partnerships with Medical Practices and Hospital Systems Valor Compounding Pharmacy, a prominent provider of compounded medications, is excited to announce its initiative to form new partnerships with medical practices and health systems. This effort aims…
New Leadership Team Set to Drive Growth and Innovation in Precision Medicine MedGenome, a leader in multiomics and precision medicine, has announced the appointment of Felix Olale, M.D., Ph.D., as President and Chief Executive Officer, and Jennifer Rose as Executive…
NImmune Biopharma, a late-clinical-stage biopharmaceutical company specializing in precision inflammation and immunology (I&I) therapeutics, has announced the acquisition of development and commercialization rights to omilancor across several Asian markets, including China, Hong Kong, Taiwan, South Korea, and others. This transaction…
Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the emerging space economy, has announced an exciting new mission to the International Space Station (ISS) in collaboration with global biopharmaceutical giant Bristol Myers Squibb (BMS). The mission will utilize…
Nucleus RadioPharma announced the development of two new facilities, totaling over 100,000 square feet, in Mesa, Arizona, and Spring House, Pennsylvania. These state-of-the-art sites will integrate research, development, and commercial production under one roof, providing significant time and scale advantages…
NUCLIDIUM today announced the successful imaging of the first patient in a Phase 1 clinical trial evaluating its radiotracer candidate as a safe and effective diagnostic and disease-staging tool in prostate cancer patients. The candidate, 61Cu-NuriPro™ (61Cu-NODAGA-PSMA I&T), is part…
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect against serious infectious diseases, and its affiliate CyanVac LLC, today announced the presentation of…